Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Elliot M. Landaw, M.D., Ph.D.
Elliot M. Landaw, M.D., Ph.D.


Professor and Chair, Department of Biomathematics
Member, JCCC Patients and Survivors Program Area

Contact Information:

(310) 825-6743

Scientific Interest(s):

Dr. Elliot Landaw's research interests center on kinetic analysis, compartmental modeling, nonlinear estimation and optimization problems in pharmacokinetics, physiology and molecular biology. His methodological interests in parameter estimation, optimal/robust sampling designs and adaptive control for computational models address problems arising from a variety of collaborations with experimental and clinical groups. Applied projects include the optimal design of DNA-sequence reading molecules, the use of model-based adaptive control for cancer chemotherapy and modeling glucose transport across the blood-brain barrier.

Selected Cancer-Related Publications:

Skaggs BJ, Gorre ME, Ryvkin A, Burgess MR, Xie Y, Han Y, Komisopoulou E, Brown LM, Loo JA, Landaw EM, Sawyers CL, Graeber TG. Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants. Proc Natl Acad Sci U S A. 2006; 103:19466-71.

Kim G, Rajasekaran SA, Thomas G, Rosen EA, Landaw EM, Shintaku P, Lassman C, Said J, Rajasekaran AK. Renal clear-cell carcinoma: an ultrastructural study on the junctional complexes. Histol Histopathol. 2005; 20:35-44.

Shankar DB, Cheng JC, Kinjo K, Federman N, Moore TB, Gill A, Rao NP, Landaw EM, Sakamoto KM. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell. 2005; 7:351-62.

Crans-Vargas HN, Landaw EM, Bhatia S, Sandusky G, Moore TB, Sakamoto KM. Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. Blood. 2002; 99:2617-2619.

Lopez AM, Pegram MD, Slamon DJ, Landaw EM. A model-based approach for assessing in vivo combination therapy interactions. Proc Natl Acad Sci U S A. 1999; 96:13023-13028.